| Literature DB >> 32767563 |
Detlef Obal1,2,3, Joseph C Wu1,4,5.
Abstract
Recent advances in human induced pluripotent stem cell (iPSC) technology may provide unprecedented opportunities to study patient-specific responses to anaesthetics and opioids. In this review, we will (1) examine the advantages and limitations of iPSC technology, (2) summarize studies using iPSCs that have contributed to our current understanding of anaesthetics and opioid action on the cardiovascular system and central nervous system (CNS), and (3) describe how iPSC technology can be used to further develop personalized analgesic and sedative pharmacotherapies with reduced or minimal detrimental cardiovascular effects.Entities:
Keywords: anaesthetics; brain; cardiomyocyte; iPSC; ketamine; opioids; propofol
Mesh:
Substances:
Year: 2020 PMID: 32767563 PMCID: PMC7520445 DOI: 10.1111/bph.15228
Source DB: PubMed Journal: Br J Pharmacol ISSN: 0007-1188 Impact factor: 8.739